Palo Alto, CA, United States of America

Maryka Quik

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maryka Quik: Innovator in Therapeutic Treatments

Introduction

Maryka Quik is a prominent inventor based in Palo Alto, CA, known for her significant contributions to the field of therapeutic treatments. With a focus on reducing side effects associated with dopaminergic agent treatments, her work has the potential to improve the quality of life for many patients.

Latest Patents

Maryka holds 1 patent for her invention titled "Methods and compositions for reduction of side effects of therapeutic treatments." This invention provides compositions and methods utilizing a nicotinic receptor modulator to reduce or eliminate side effects associated with dopaminergic agent treatment. In some embodiments, her invention combines a dopaminergic agent with a nicotinic receptor modulator to effectively address these side effects.

Career Highlights

Maryka Quik is affiliated with the Parkinson's Institute, where she applies her expertise to advance research and development in therapeutic solutions. Her innovative approach has garnered attention in the medical community, particularly for its implications in treating Parkinson's disease and related conditions.

Collaborations

Maryka has collaborated with notable colleagues, including Donato Di Monte and J. William Langston, who share her commitment to advancing therapeutic treatments. Their combined efforts contribute to a deeper understanding of the complexities involved in managing side effects of dopaminergic therapies.

Conclusion

Maryka Quik's work exemplifies the intersection of innovation and healthcare, showcasing her dedication to improving therapeutic outcomes for patients. Her contributions are paving the way for advancements in treatment methodologies that could significantly enhance patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…